ILPA releases new continuation fund guidance
The Institutional Limited Partners Association (ILPA) recently announced new guidance regarding the formation and offering of...
Contributors
-
Associate -
Trainee -
Partner -
Trainee -
Counsel -
Partner -
Trainee -
Partner -
Counsel -
Associate
-
Partner -
Partner -
Partner -
Partner -
Associate
-
Director of Human Resources, London
-
Partner -
Senior Lab Consultant and Behavioral Scientist -
Associate -
Antitrust Professional Support Lawyer
-
Partner -
Counsel -
Associate -
Associate
-
Associate -
Counsel -
Associate -
Partner -
Partner -
Counsel -
Partner -
Counsel -
Associate -
Associate -
Trainee -
Partner -
Associate -
Partner -
Associate -
Partner -
International Pro Bono -
Associate -
Associate -
Trainee -
Associate -
Associate -
Partner -
Senior Adviser -
Partner -
Trainee -
Associate
-
Partner -
Partner -
Partner -
Associate -
Senior Manager, Professional Development and Training -
Associate -
Trainee -
Chief of Change and Engagement -
Trainee -
Trainee -
Associate -
Associate -
Counsel -
Trainee -
Associate -
Partner -
Counsel -
Associate -
Trainee
-
Associate -
Partner -
Director of Operations and Delivery -
Partner -
Trainee -
Associate -
Associate -
Trainee Solicitor -
Associate -
Director of Behavioral Insights -
Associate -
Counsel -
Associate -
Counsel -
Associate -
Partner -
Associate -
Partner -
Associate -
Associate -
Partner -
Associate -
Associate -
Counsel -
Partner -
Trainee -
-
Partner -
Associate -
Partner -
Counsel -
Associate -
Associate -
Associate -
Partner -
Associate
-
Partner -
Associate -
Partner -
Associate -
Partner -
Trainee -
Trainee -
Managing Principal and Head of Innovation of R&G Insights Lab -
Associate
Ropes & Gray Archive
- May 2023 (22)
- April 2023 (18)
- March 2023 (24)
- February 2023 (17)
- January 2023 (27)
- December 2022 (11)
- November 2022 (22)
- October 2022 (12)
- September 2022 (9)
- August 2022 (5)
- July 2022 (7)
- June 2022 (8)
- May 2022 (10)
- April 2022 (7)
- March 2022 (18)
- February 2022 (6)
- January 2022 (12)
- December 2021 (10)
- November 2021 (16)
- October 2021 (7)
- September 2021 (10)
- August 2021 (12)
- July 2021 (22)
- June 2021 (17)
- May 2021 (10)
- April 2021 (9)
- March 2021 (7)
- February 2021 (13)
- January 2021 (19)
- December 2020 (14)
- November 2020 (11)
- October 2020 (16)
- September 2020 (12)
- August 2020 (13)
- July 2020 (32)
- June 2020 (19)
- May 2020 (33)
- April 2020 (38)
- March 2020 (53)
- February 2020 (22)
The Chancellor unveils £650 million package to drive growth in British life sciences
Jeremy Hunt, the Chancellor, has this week revealed his ‘Life Sci for Growth’. Consisting of a multi-prong approach, it follows the...
From likes to strikes: the implications of the record-breaking €1.2 billion GDPR fine
On 22 May 2023, the Irish data protection regulator (DPC) announced that it had issued a record-breaking €1.2 billion fine in a decision...
The one with the snazzy compliance training videos
The Wall Street Journal reported last week that Microsoft employees are hooked on a series of compliance training videos. Blockbuster...
A new regulatory regime for the UK’s digital economy
On 25 April 2023, the UK’s much anticipated Digital Markets, Competition and Consumers Bill (the Bill) was published. The Bill has three...
ICO publishes new guidance on responding to subject access requests
The right of subject access has long been regarded as critical in ensuring that organisations that collect and use individuals' personal...
Sanctions evasion guidance for high value dealers and art market participants
The UK’s Office of Financial Sanctions Implementation (OFSI) released guidance aimed to help “high value dealers” and art market...
Why start-ups and venture funds need to take note of the Labour Party
Labour Shadow Chancellor, Rachel Reeves, is using a trip to the US to continue the Labour Party’s push to be seen as the party of...
Financial services: banking on AI?
Last week I had the pleasure of speaking on a panel at the NICE Actimize conference in London, where we explored the applications,...
Why pharma should pay attention to the Labour Party’s plans for the NHS and clinical trials
In the wake of the Conservative Party’s bruising local election results, there is a continued focus on what a Labour-led Government might...
Relaunch of the EMA’s policy on the proactive publication of clinical data
In September 2023, the European Medicines Agency (EMA) will reinstate Policy 0070 (the Policy), pursuant to which clinical data submitted...
PE-backed possible offers driving uptick in UK takeover activity
Although 2022 was a comparatively quiet year for private equity-backed takeovers of UK-listed companies, 2023 has seen an uptick in...
UK's NCSC and ICO encourage greater transparency around cyber attacks
It seems that cyber attacks, particularly through the use of ransomware, continue to pose a serious threat to UK businesses. It was...
Call of Duty: The proposed reform of UK stamp taxes on shares
HMRC’s recently-launched Stamp Taxes on Shares modernisation consultation gives welcome new impetus to the much-needed reform of the UK...
Further details revealed regarding the EU’s proposed 11th package of sanctions against Russia
On May 9, 2023, in a press statement with Ukrainian President Volodymyr Zelenskyy, President of the European Commission, Ursula von der...
Controversy around the UK's Online Safety Bill continues
The debate concerning the UK's controversial Online Safety Bill (OSB) has continued to rumble on in recent days, with the UK Government...
What British start-ups can learn from Swiss Biotech Day 2023
We recently discussed the key trends from the recent Swiss Biotech Day. However, there is so much to take away that it is worth...
SEC amends Form PF - implications for private fund advisers and the secondaries market
On May 3, 2023, the U.S. Securities and Exchange Commission (SEC) adopted amendments to Form PF, the confidential reporting form for...
The FCA fights back in the competition for listings
We have recently discussed how the US remains the preferred listing destination for many European companies, particularly those in the...
CJEU AGs issue two opinions on GDPR liability
James Brown may have been the hardest working man in showbusiness, but spare a thought for the advocates general of the Court of Justice...
Are liability management exercises going to happen in Europe?
Talking about liability management exercises in Europe is interesting stuff for advisers, but we’ve not seen them occur with the...
Why the U.S. remains the preferred listing choice for European biotechs (even in the current market)
Earlier this year, the UK Government published its Science and Technology Framework to support the life sciences sector. A trailed...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net